Cyclerion Therapeutics
AcquiredCyclerion
Cambridge, United States · Founded 2019
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- cyclerion.com
- Last Round
- Venture RoundMay 2023
- Rounds
- 3
About
Clinical-stage biopharmaceutical company developing treatments for neuropsychiatric diseases, including CYC-126 for treatment-resistant depression.
Summary
Cyclerion Therapeutics is a Biotech company based in Cambridge, United States, founded in 2019. Its most recent funding was a Venture Round round in May 2023. Investors include EcoR1 Capital, Ironwood Pharmaceuticals and Slate Path Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2026
Sign up to see all 7 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...